-transparent.png){kind=logo}
Selective estrogen receptor modulator (SERM) is a kind of drug that has agonistic and antagonistic effects of estrogen in different tissues. MORE study has shown that raloxyfene reduces osteoporotic vertebral fractures and serum cholesterol levels in postmenopausal women, while it does not stimulate the endometrium and decreases the breast cancer occurrence. There are more to be investigated like developing newer SERMs, a combination therapy with estrogen or the elucidation of mechanisms of estrogen effects.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Akira Itabashi
March 2005,
Nihon rinsho. Japanese journal of clinical medicine,
Akira Itabashi
November 2000,
The Journal of pharmacology and experimental therapeutics,
Akira Itabashi
January 2000,
Joint bone spine,
Akira Itabashi
May 2007,
The Journal of steroid biochemistry and molecular biology,
Akira Itabashi
June 1999,
JAMA,
Akira Itabashi
November 2004,
Journal of agricultural and food chemistry,
Akira Itabashi
January 2014,
Clinical calcium,
Akira Itabashi
November 2014,
Steroids,
Akira Itabashi
July 2012,
Chemical research in toxicology,
